Ansuman Satpathy

Ansuman Satpathy

Associate Professor, Pathology
Member, Bio-X
Member, Maternal & Child Health Research Institute (MCHRI)
Faculty Fellow, Sarafan ChEM-H
Member, Stanford Cancer Institute
Member, Wu Tsai Neurosciences Institute
Postdoc, Stanford University, Genetics (2019)
Residency, Stanford Hospital and Clinics, Clinical Pathology (2017)
Ph.D., Washington University in St. Louis, Immunology (2014)
M.D., Washington University in St. Louis, Medicine (2014)
Visiting Scholar, King's College London, Computational Biology (2005)
B.A., University of Illinois, Urbana-Champaign, Philosophy (2006)
B.S., University of Illinois, Urbana-Champaign, Molecular Biology (2006)
Dr. Ansuman Satpathy, M.D., Ph.D., is a physician-scientist and Associate Professor of Pathology and Immunology at Stanford University. He is the director of the Stanford Center for Immunotherapy Design, co-director of the Parker Institute for Cancer Immunotherapy, and co-director of the Immunotherapy Program in the Stanford Cancer Institute. Ansu's research combines expertise in immunology, high-throughput genomics, and computation to discover principles of the immune system in health and disease and to translate these discoveries into novel clinical therapeutics. He is a co-founder of Immunai, Cartography Biosciences, Santa Ana Bio, and Prox Biosciences, and a venture partner at Wing Venture Capital.

Ansu holds a BS in molecular biology and BA in philosophy from the University of Illinois, an MD and PhD in immunology from Washington University in St.Louis, and completed his clinical residency and postdoctoral training in genetics at Stanford University.